Indication

Glioblastoma multiforme

Glioblastoma multiforme is a fast-growing, highly aggressive grade 4 central nervous system malignancy arising from supportive glial tissue, predominantly astrocytes. Read more about Glioblastoma multiforme

48 drugs 41 manufacturers

Advertisement

Drugs that treat it

Common Glioblastoma multiforme therapies.

Showing 28–36 of 48 drugs

ALYMSYS (bevacizumab-maly)

VASCULAR ENDOTHELIAL GROWTH FACTOR(VEGF) MONOCLONAL ANTIBODY·METASTATIC COLORECTAL CANCER·+5
Amneal Pharmaceuticals

VEGZELMA (bevacizumab-adcd)

VASCULAR ENDOTHELIAL GROWTH FACTOR(VEGF) MONOCLONAL ANTIBODY·METASTATIC COLORECTAL CANCER·+5
CELLTRION USA,

TEMOZOLOMIDE

ALKYLATING AGENTS·ANAPLASTIC ASTROCYTOMA·+1
CAMBER PHARMACE

TEMOZOLOMIDE

ALKYLATING AGENTS·ANAPLASTIC ASTROCYTOMA·+1
AVPAK

CARMUSTINE

NITROSOUREAS·MALIGNANT BRAIN NEOPLASM·+6
DR.REDDY'S LAB

CARMUSTINE

NITROSOUREAS·MALIGNANT BRAIN NEOPLASM·+6
ALEMBIC PHARMAC

CARMUSTINE

NITROSOUREAS·MALIGNANT BRAIN NEOPLASM·+6
ATHENEX PHARMAC

CARMUSTINE

NITROSOUREAS·MALIGNANT BRAIN NEOPLASM·+6
MEITHEAL PHARMA
Filter & compare in the drug finder →Opens the drug finder with Glioblastoma multiforme preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Glioblastoma multiforme.

Glioblastoma multiforme is a fast-growing, highly aggressive grade 4 central nervous system malignancy arising from supportive glial tissue, predominantly astrocytes.

It represents the most common primary malignant brain tumor in adults, primarily affecting the cerebral hemispheres and rarely the spinal cord.

Pathophysiologically, the tumor is characterized by poorly differentiated pleomorphic glial cells, brisk mitotic activity, prominent microvascular proliferation, and extensive areas of necrosis.

Clinically, its rapid growth and diffuse infiltration into surrounding brain parenchyma lead to progressive neurological deficits, seizures, and signs of elevated intracranial pressure, such as severe headaches and cognitive changes.

Personalize your experience

Follow Glioblastoma multiforme and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it